RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
CSPC Pharmaceutical Group Stock

CSPC Pharmaceutical Group Employees 2024

CSPC Pharmaceutical Group Employees

17,292

Ticker

1093.HK

ISIN

HK1093012172

WKN

548183

In 2024, CSPC Pharmaceutical Group employed 17,292 people, a 0% change from the 17,292 number of employees in the previous year.

CSPC Pharmaceutical Group Aktienanalyse

What does CSPC Pharmaceutical Group do?

CSPC Pharmaceutical Group Ltd. is a leading pharmaceutical company in China. It was founded in 1997 and specializes in the manufacturing of pharmaceutical raw materials, intermediates, and finished drugs. The company's product range covers various therapy areas and provides a variety of medications for patients worldwide. The company's business model is based on research, development, and production of pharmaceutical products for the mass market. In 2019, CSPC Pharmaceutical achieved a revenue of 9.9 billion USD. The company's products are represented in 24 countries worldwide and aim to improve people's lives through innovations in the healthcare sector. CSPC Pharmaceutical has various divisions, including its sister company CSPC Zhongqi Pharmaceutical Technology Co. Ltd., which specializes in innovative technologies for drug manufacturing. Other divisions include CSPC Weisheng Pharmaceutical Co. Ltd. for marketing and distribution in China, as well as CSPC Ouyi Pharmaceutical Co. Ltd. for the production of traditional Chinese medicines. The product range of CSPC Pharmaceutical is diverse and offers medications for various application areas. This includes cancer therapy with products such as Anastrozole tablets and Vinorelbine injection solution. In the field of cardiovascular diseases, CSPC Pharmaceutical offers Metoprolol Succinate tablets. Additionally, the company provides products for the treatment of pain and inflammation, such as Ibuprofen suspension and generic versions of Celecoxib. Another focus of the company is the research and production of antibiotics, which are important medications in the treatment of bacterial infections. CSPC Pharmaceutical produces a wide range of antibiotics in different dosage forms, including Cefazolin Sodium injection solutions and Cefalotin Sodium injection solutions. Throughout its history, CSPC Pharmaceutical has received various awards and certifications that confirm the high quality of its products. In 2019, the company was honored as the "Best Innovative Pharmaceutical Firm" at the Asia-Pacific Biotech Industry Awards. Furthermore, CSPC Pharmaceutical has obtained the ISO 9001:2015 Quality Management System certificate, and its products are approved by the US FDA, the European Medicines Agency, and the National Medical Products Administration in China. Overall, CSPC Pharmaceutical is an important player in the Chinese pharmaceutical market, offering a wide product range and increasing the level of innovation through research and development. With its continuous growth and efforts towards quality and innovation, CSPC Pharmaceutical will continue to play a significant role in the global healthcare market. CSPC Pharmaceutical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining CSPC Pharmaceutical Group's Employee Base

CSPC Pharmaceutical Group's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding CSPC Pharmaceutical Group's operational capacity and future potential.

Year-to-Year Comparison

Assessing CSPC Pharmaceutical Group's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

CSPC Pharmaceutical Group's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in CSPC Pharmaceutical Group’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about CSPC Pharmaceutical Group stock

How many employees does CSPC Pharmaceutical Group have this year?

CSPC Pharmaceutical Group has 17,292 undefined employees this year.

How many employees did CSPC Pharmaceutical Group have compared to the previous year?

Compared to the previous year, CSPC Pharmaceutical Group had 0% more employees.

What impact did the number of employees have on the company CSPC Pharmaceutical Group?

The number of employees has a direct impact on the efficiency and productivity of CSPC Pharmaceutical Group. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of CSPC Pharmaceutical Group?

The number of employees can also have an impact on investors of CSPC Pharmaceutical Group, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of CSPC Pharmaceutical Group affect the company?

An increase in equity of CSPC Pharmaceutical Group can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in CSPC Pharmaceutical Group's equity affect the company?

A reduction in equity of CSPC Pharmaceutical Group can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of CSPC Pharmaceutical Group?

Some factors that can influence the equity of CSPC Pharmaceutical Group include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of CSPC Pharmaceutical Group so important for investors?

The equity of CSPC Pharmaceutical Group is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at CSPC Pharmaceutical Group influence the company?

The number of employees at CSPC Pharmaceutical Group can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at CSPC Pharmaceutical Group evolved in recent years?

In recent years, the number of employees at CSPC Pharmaceutical Group has changed by 0.

How many employees does CSPC Pharmaceutical Group currently have?

CSPC Pharmaceutical Group currently has 17,292 undefined employees.

Why is the number of employees important for investors of CSPC Pharmaceutical Group?

The number of employees is important for investors of CSPC Pharmaceutical Group as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can CSPC Pharmaceutical Group take to change the number of employees?

To change the number of employees, CSPC Pharmaceutical Group can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does CSPC Pharmaceutical Group pay?

Over the past 12 months, CSPC Pharmaceutical Group paid a dividend of 0.25 CNY . This corresponds to a dividend yield of about 5.3 %. For the coming 12 months, CSPC Pharmaceutical Group is expected to pay a dividend of 0.28 CNY.

What is the dividend yield of CSPC Pharmaceutical Group?

The current dividend yield of CSPC Pharmaceutical Group is 5.3 %.

When does CSPC Pharmaceutical Group pay dividends?

CSPC Pharmaceutical Group pays a quarterly dividend. This is distributed in the months of June, July, November, December.

How secure is the dividend of CSPC Pharmaceutical Group?

CSPC Pharmaceutical Group paid dividends every year for the past 17 years.

What is the dividend of CSPC Pharmaceutical Group?

For the upcoming 12 months, dividends amounting to 0.28 CNY are expected. This corresponds to a dividend yield of 5.96 %.

In which sector is CSPC Pharmaceutical Group located?

CSPC Pharmaceutical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von CSPC Pharmaceutical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of CSPC Pharmaceutical Group from 11/20/2024 amounting to 0.02 CNY, you needed to have the stock in your portfolio before the ex-date on 11/4/2024.

When did CSPC Pharmaceutical Group pay the last dividend?

The last dividend was paid out on 11/20/2024.

What was the dividend of CSPC Pharmaceutical Group in the year 2023?

In the year 2023, CSPC Pharmaceutical Group distributed 0.2 CNY as dividends.

In which currency does CSPC Pharmaceutical Group pay out the dividend?

The dividends of CSPC Pharmaceutical Group are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von CSPC Pharmaceutical Group

Our stock analysis for CSPC Pharmaceutical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CSPC Pharmaceutical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.